HPGC Renmintongtai Pharmaceutical (SHSE:600829) Total Stockholders Equity : ¥2,874 Mil (As of Sep. 2024)

View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical Total Stockholders Equity?

HPGC Renmintongtai Pharmaceutical's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ¥2,874 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. HPGC Renmintongtai Pharmaceutical's Book Value per Share for the quarter that ended in Sep. 2024 was ¥4.96. The ratio of a company's debt over equity can be used to measure how leveraged this company is. HPGC Renmintongtai Pharmaceutical's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.33.

HPGC Renmintongtai Pharmaceutical Total Stockholders Equity Historical Data

The historical data trend for HPGC Renmintongtai Pharmaceutical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPGC Renmintongtai Pharmaceutical Total Stockholders Equity Chart

HPGC Renmintongtai Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,847.28

1,992.54

2,200.25

2,459.26

2,751.42

HPGC Renmintongtai Pharmaceutical Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															2,704.24	2,751.42	2,829.75	2,803.11	2,873.95

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

HPGC Renmintongtai Pharmaceutical's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2873.948	-	0)	/	579.889
	=	4.96

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

HPGC Renmintongtai Pharmaceutical's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(925.102	+	20.452)	/	2873.948
	=	0.33

HPGC Renmintongtai Pharmaceutical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

HPGC Renmintongtai Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076

Website

http://www.sanjing.com.cn

HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.

Executives

Yue Xian Zhi	senior management
Zhang Li Jun	Director

HPGC Renmintongtai Pharmaceutical Headlines

No Headlines